The company's last traded volume of 2.71 million shares was up it's an average volume of 6.53 million shares. The stock's market capitalization is 99.73M, it has a 52-week low of 0.13 and a 52-week high of 0.71. The stock has a 50 day moving average of $0.47 and a 200-day moving average of $0.25. This is a near-term outlook for the coming 12-18 months. Generally speaking, earnings are expected to hold steady in coming quarters. Future earnings predictions are perhaps the most essential input when trying to value a company. The Lower end of the earnings estimate is $-0.03, while the higher end of the earnings estimate is $0. (RNN) is its Earnings per Share or EPS.
Despite the fact American Tower Corporation (NYSE:AMT) was trading at volume above average, prior 52-week high was $124.40 and surged 20.74% over the same period, trading at a volume of 2.44 million. The company reported revenue of $0 in the same period previous year. RNN generated revenue of $0 in the same quarter, one year ago. If the share price is now hovering near the 52 week low and the value is achieved in the current past then it can suggest that the price of the shares is likely to go up. Price Target plays a critical role when it comes to the analysis of a Stock.
04/05/2017 - H.C. Wainwright began new coverage on Rexahn Pharmaceuticals, Inc. giving the company a " rating.
A moving average (MA) is a trend-following or lagging indicator because it is based on past prices.
Latest analyst recommendations could offer little help to investors. For RNN, the company now has $11.58 Million of cash on the books. The ROA ratio is calculated by comparing net income to average total assets, and is expressed as a percentage.
Amid volatile financial markets and the presidential election, various investment brokerages have made amendments to their price targets and ratings on shares of Rexahn Pharmaceuticals, Inc. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements.
The Return on Investment (ROI) ratio of Rexahn Pharmaceuticals, Inc. The Return on Equity ratio of Rexahn Pharmaceuticals, Inc. Following the transaction, the director now owns 6,260,000 shares of the company's stock, valued at $4,382,000.
According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 1 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell. The stock has relative volume of 1.64. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward.
During last one year month it performed at 27.61%.
Menendez lawyer says senator will be vindicated
He would also order unnecessary tests and treatments for some patients at his eye clinic in West Palm Beach, prosecutors said. Attorney's Office for the Southern District of Florida and Melgen's lawyers could not be immediately reached for comment.
Modi Urges Muslims Not to Politicise Triple Talaq
The prime minister spoke about women's empowerment, equality and good governance, as preached and practised by Basaveswara. He further asserted that irrespective of any kind of discrimination every person should own a house.